Funded Tech Companies
TCR2 Therapeutics
Looking for the VC firms that provided funding to TCR2 Therapeutics? Curative Ventures, Alexandria Venture Investments and Mirae Asset Venture Investment joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
TCR2 Therapeutics
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
100 Binney St. 710
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Company Background Information
Overview
TCR2, Inc. (Nasdaq: TCRR) is a pharmaceutical company focused on engineering T cells for cancer therapy.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/13/2019
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Garry Menzel
Chief Financial Officer
Ian Somaiya
Chief Medical Officer
Alfonso Cardama
Chief Scientific Officer
Robert Hofmeister
VP - Bus. Development
Andrew Cornforth
VP - Operations
Amy Lynch
VP - R & D
Daniel Getts
Company Investors
- Curative Ventures
- Alexandria Venture Investments
- Mirae Asset Venture Investment
- Leerink Partners
- 6 Dimensions Capital (Wei Li)
- Hillhouse Capital Group
- F2 Ventures
- Syno Capital
- Lucion
- MPM Capital
- Cathay Fortune Capital Investment
- Sirona Capital
- Haitong International Securities
- Redmile Group
- ArrowMark Partners
Browse more funded tech companies:
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs